McIntyre, Christine

Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study

Davies, A., Merli, F., Mihaljevic, B., Siritanaratkul, N., Solal-Céligny, P., Barrett, M., Berge, C., Bittner, B., Boehnke, A., McIntyre, C., et al. (2014) · The Lancet Oncology

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 114

Use of a Population Pharmacokinetic Approach for the Clinical Development of a Fixed‐Dose Subcutaneous Formulation of Trastuzumab

Hourcade‐Potelleret, F., Lemenuel‐Diot, A., McIntyre, C., Brewster, M., Lum, B., & Bittner, B. (2014) · CPT: Pharmacometrics & Systems Pharmacology

Pharmaceutical studies and practicesHER2/EGFR in Cancer Research

Cited by 28

Pharmacokinetics and pharmacodynamics of single subcutaneous doses of tocilizumab administered with or without rHuPH20

Morcos, P. N., Zhang, X., McIntyre, C., Bittner, B., Rowell, L., & Hussain, Z. (2013) · Int. Journal of Clinical Pharmacology and Therapeutics

Rheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical Methods

Cited by 23